Fangjia Tong

544 citations
17 papers · 396 indexed · h-index 11
Topics
Cancer-related molecular mechanisms research (6 papers)Extracellular vesicles in disease (4 papers)MicroRNA in disease regulation (4 papers)
Partner nations
ChinaUnited StatesTaiwan

In The Last Decade

Fangjia Tong

16 papers receiving 395 citations

Peers

Fangjia Tong
Comparison fields: 5 of 43
  • Molecular Biology 220
  • Cancer Research 171
  • Oncology 126
  • Immunology 122
  • Otorhinolaryngology 83
Replace Makiko Moriyama‐Kita with:
Makiko Moriyama‐Kita Japan
Thomas Brunhuber Austria
Takeshi Kuroshima Japan
Evangelia Michailidou Greece
Touraj Taheri Australia
Brian Lane United Kingdom
Giulia Pagano Spain
Mattias Jangard Sweden
Nadine C. Olthof Netherlands
Christina A. Marsh United States
Fangjia Tong relative to Makiko Moriyama‐Kita Japan Makiko Moriyama‐Kita's profile →
Citations per field
00.5×1.5×2.5×
Makiko Moriyama‐Kita · 1×
Citations per year

Countries citing papers authored by Fangjia Tong

Since Specialization
Citations

This map shows the geographic impact of Fangjia Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangjia Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangjia Tong more than expected).

Fields of papers citing papers by Fangjia Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangjia Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangjia Tong. The network helps show where Fangjia Tong may publish in the future.

Co-authorship network of co-authors of Fangjia Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Fangjia Tong. A scholar is included among the top collaborators of Fangjia Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangjia Tong. Fangjia Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 1
2 0
3 5
4 8
5 26
6 13
7 7
8 27
9 88
10 22
11 17
12 54
13 1
14 22
15 26
16 64
17 15

About Fangjia Tong

Fangjia Tong is a scholar working on Otorhinolaryngology, Cancer Research and Oncology, having authored 17 papers that have together received 396 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Extracellular vesicles in disease (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Otorhinolaryngology (83 citations), Cancer Research (171 citations) and Immunology (122 citations). Fangjia Tong has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Lanlan Wei, Bingqing Yan, Xionghui Mao, Ji Sun, Bozhi Wang, Huanhuan Xie, Siwei Zhang, Xiaohang Chen, Fengmin Zhang and Xiaowei Wang. Their work appears in journals such as Journal of Clinical Investigation, Scientific Reports and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026